Gujarat Apollo Industries has completed the sale of its entire 17.92% stake in Credo Advanced Chemicals Limited for Rs 37.63 crore. The transaction was finalized on October 6, 2026, marking a complete exit from the unlisted entity. This move converts a non-core investment into cash, though the company is yet to disclose plans for the capital deployment. Shareholders should watch for updates on how these proceeds will be utilized for future operations or debt management.
Gujarat Apollo Industries Exits Credo Advanced Chemicals
Total Consideration: Rs 37.63 crore. Stake Sold: 17.92% (1,34,40,000 equity shares).
Reader Takeaway: Divestment converts non-core assets into liquid cash; shareholders await management guidance on capital deployment plans.
What just happened
Gujarat Apollo Industries has successfully concluded the sale of its entire shareholding in Credo Advanced Chemicals Limited. The company offloaded 1,34,40,000 equity shares, amounting to a 17.92% stake, for a total cash consideration of Rs 37.63 crore. The transaction was completed on October 6, 2026. This exit follows formal approvals from the Board of Directors on September 3, 2026, and subsequent shareholder approval under the relevant provisions of the Companies Act and SEBI regulations. Deloitte Touche Tohmatsu India LLP served as the exclusive advisor for this deal.
Why this matters
For investors, the primary impact is the immediate infusion of liquidity into Gujarat Apollo Industries. By divesting from this unlisted chemical venture, the company has converted a long-term non-core asset into cash. This clean exit simplifies the corporate structure and provides a boost to the company's cash reserves, which can be deployed toward core business activities, debt reduction, or other growth opportunities.
What changes now
Gujarat Apollo Industries no longer holds any equity in Credo Advanced Chemicals. The balance sheet will reflect the cash inflow from the sale, and the entity is now entirely removed from the company's investment portfolio. With no residual interest, the company is no longer exposed to the operational risks or performance fluctuations of Credo Advanced Chemicals.
What to track next
The market will now look to management for clarity on the usage of the Rs 37.63 crore proceeds. Investors should monitor future earnings calls and upcoming disclosures for information regarding capital allocation, potential debt repayment, or reinvestment strategies that could impact the company's long-term valuation.